Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection

American Journal of Transplantation

Volumn 11, Issue 10, 2011, Pages 2228-2234

  Jackson, J A ^a,b   Kim, E J ^a,b   Begley, B ^a,b   Cheeseman, J ^a,b   Harden, T ^a,b   Perez, S D ^a,b   Thomas, S ^a,b   Warshaw, B ^a,b   Kirk, A D ^a,b  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Chemokines; immune monitoring; kidney transplantation; pediatric

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; ARTICLE; BK VIRUS; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; VIRUS INFECTION;

BIOLOGICAL MARKERS; BK VIRUS; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHEMOKINE CXCL9; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 80053328081     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03680.x     Document Type: Article

References (33)

1. Davis ID, Oehlenschlager W, O'Riordan MA, Avner ED,. Pediatric renal biopsy: Should this procedure be performed in an outpatient setting? Pediatr Nephrol 1998; 12: 96-100. (Pubitemid 28165794)
2. Pape L, Offner G, Ehrich JH, de Boer J, Persijn GG,. Renal allograft function in matched pediatric and adult recipient pairs of the same donor. Transplantation 2004; 77: 1191-1194. (Pubitemid 38580295)
3. Provoost AP, Wolff ED, de Keijzer MH, Molenaar JC,. Influence of the recipient's size upon renal function following kidney transplantation. An experimental and clinical investigation. J Pediatr Surg 1984; 19: 63-67. (Pubitemid 14188552)
4. Hymes LC, Greenbaum L, Amaral SG, Warshaw BL,. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric patients. Pediatr Transplant 2007; 11: 536-539. (Pubitemid 47057333)
5. Mengel M, Chapman JR, Cosio FG, et al,. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007; 7: 512-517. (Pubitemid 46376459)
6. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242-249.
7. Moreso F, Ibernon M, Gomà M, et al,. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6 747-752. (Pubitemid 43345012)
8. Rush D, Nickerson P, Gough J, McKenna R, Grimm P,. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 2129-2134. (Pubitemid 28482163)
9. Hu H, Kwun J, Aizenstein BD, Knechtle SJ,. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation 2009; 87: 1814-1820.
10. Schaub S, Nickerson P, Rush D, Mayr M, Hess C, Golian M, et al,. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant 2009; 9: 1347-1353.
11. Tatapudi RR, Muthukumar T, Dadhania D, et al,. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390-2397. (Pubitemid 38670025)
12. Segerer S, Cui Y, Eitner F, et al,. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531. (Pubitemid 32195291)
13. Hauser IA, Spiegler S, Kiss E, et al,. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 2005; 16: 1849-1858. (Pubitemid 41716493)
14. Matz M, Beyer J, Wunsch D, et al,. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006; 69: 1683-1690.
15. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ,. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 2004; 4: 432-437. (Pubitemid 38282301)
16. Rossio JL, Button E, Zhao B, Shi J, Beernink H, Meegan J,. Urine-based biomarkers for kidney damage: Novel assay for monitoring transplant patients. ASHI Quarterly 2009; 3: 82-86.
17. Feltran Lde S, Nogueira PC, Silva FA, Ajzen SA, Pacheco-Silva A,. A one year prospective comparison of kidney growth and function in children recipients of grafts from children and adults. Transplantation 2010; 90: 777-781.
18. Bohlin AB, Berg U,. Renal functional adaptation of the adult kidney following transplantation to the child. Kidney Int 1991; 39: 129-134.
19. Filler G, Sharma AP,. How to monitor renal function in pediatric solid organ transplant recipients. Pediatr Transplant 2008; 12: 393-401. (Pubitemid 351652079)
20. Hartono C, Muthukumar T, Suthanthiran M,. Noninvasive diagnosis of acute rejection of renal allograft. Curr Opin Organ Transplant 2010; 15: 35-41.
21. Li B, Hartono C, Ding R, et al,. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954. (Pubitemid 32240312)
22. Tatapudi RR, Muthukumar T, Dadhania D, et al,. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390-2397. (Pubitemid 38670025)
23. Yannaraki M, Rebibou JM, Ducloux D, et al,. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759-768. (Pubitemid 44196165)
24. Simon T, Opelz G, Wiesel M, Ott RC, Süsal C,. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003; 3: 1121-1127. (Pubitemid 37064552)
25. Lazzeri E, Rotondi M, Mazzinghi B, et al,. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograph nephropathy. Transplantation 2005; 79: 1215-1220. (Pubitemid 40664027)
26. Higurashi M, Ohya Y, Joh K, et al,. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with type 2 diabetic nephropathy. J Diabetes Complications 2009; 23: 178-184.
27. Dadhania D, Snopkowski C, Ding R, et al,. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010; 90: 189-197.
28. Kirk AD, Bollinger RR, Finn OJ,. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 1995; 43: 113-128.
29. Girlanda R, Kleiner DE, Duan Z, et al., Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant 2008; 8: 600-607. (Pubitemid 351287541)
30. Hoffmann SC, Kampen RL, Amur S, et al,. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002; 74: 916-923. (Pubitemid 35191236)
31. Zhang X, Xu H, Kampen RL, Kirk AD,. The impact of localized monocyte: Endothelial cell interactions on renal tubular epithelial cell immune. World Transplant Congress; 2006 July 24-27, 2006; Boston, MA: Am J Transplant 2006; 6 (Suppl 2): 754.
32. Hoffmann SC, Hale DA, Kleiner DE, et al,. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573-581. (Pubitemid 40313350)
33. Aquino Dias EC, Veronese FJ, Santos GonÃalves LF, Manfro RC,. Molecular markers in subclinical acute rejection of renal transplants. Clin Transplant 2004; 18: 281-287. (Pubitemid 38744852)